Comparison of the Action of the Rosiglitazone-Metformin Fixed-Dose Combination and of a Metformin-Sulfonylurea Free Combination on the b-Cell Function in Type 2 Diabetic Patients Not Controlled With Metformin Alone.

Trial Profile

Comparison of the Action of the Rosiglitazone-Metformin Fixed-Dose Combination and of a Metformin-Sulfonylurea Free Combination on the b-Cell Function in Type 2 Diabetic Patients Not Controlled With Metformin Alone.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2010

At a glance

  • Drugs Gliclazide; Metformin; Rosiglitazone/metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Oct 2008 Status changed from active, no longer recruiting to completed according to Clinicaltrials.gov record.
    • 07 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top